Intra-Cellular Therapies, now part of Johnson & Johnson, is a biopharmaceutical company founded on Dr. Paul Greengard’s Nobel Prize-winning research that uncovered how therapies affect the inner-working of cells in the body.

We leverage this intracellular approach to develop innovative treatments for people living with complex psychiatric